✕

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.

Share

Global Disease Challenges

hile the world continues to face ongoing challenges with HIV and tuberculosis, and many unknown and emerging threats, there is also an increasing shift in burden of disease toward noncommunicable diseases (NCDs) and mental health. At Johnson & Johnson, we are passionate about our work to save and improve people’s lives. We forge partnerships and identify new ways to pioneer human ingenuity to accelerate the development of new drug regimens, support the strengthening of healthcare systems and break down barriers to access in resource-limited settings.

Global Disease Challenges

expand

Our Aspiration: A world where innovations and holistic health solutions prevent, control and eliminate global disease challenges and epidemics.

5-Year Target: 175 million individuals will have benefited from Johnson & Johnson solutions that prevent, control and eliminate global diseases.

Status: Exceeded

Our Impact:

• How a Small Chewable Tablet Is Helping Tackle a Disease That Impacts Nearly 1 Billion Children Globally

• New Horizons Collaborative: Addressing Needs of Children Impacted by HIV

• As 2030 Deadline Looms We Must Accelerate Progress Against TB

Global Mental Health
& Well-Being

Our Mission to End HIV

Enabling a World Without TB

Enabling a World Without TB

India

How Johnson & Johnson Is Helping Tackle a Devastating Tropical Disease That Impacts Kids

How Johnson & Johnson Is Helping Tackle a Devastating Tropical Disease That Impacts Kids

Two smiling young girls

Johnson & Johnson's COVID-19 Vaccine

New Pediatric Formulation of Janssen’s Treatment for Intestinal Worms Achieves World Health Organization Prequalification

New Pediatric Formulation of Janssen’s Treatment for Intestinal Worms Achieves World Health Organization Prequalification

“I Was on the Ground During the HIV Epidemic": Meet the Scientist Who's Sharing the Spotlight With Celebs at the Global Citizen Festival

“I Was on the Ground During the HIV Epidemic": Meet the Scientist Who's Sharing the Spotlight With Celebs at the Global Citizen Festival

Dr. Paul Stoffels, Johnson & Johnson Chief Scientific Officer, at 2017 Global Citizen Festival

Ending MDR-TB: “It’s Doable. Let’s Solve It”

Ending MDR-TB: “It’s Doable. Let’s Solve It”

The Global Fund, Stop TB, The Economist and WEF joined Johnson & Johnson in the coLaboratory for the Future

Johnson & Johnson Announces Partnership with CSIR-IMTECH to Develop Innovative New Tuberculosis Treatments

Johnson & Johnson Announces Partnership with CSIR-IMTECH to Develop Innovative New Tuberculosis Treatments

The New Ebola Clinical Trial That's Focused on Helping Halt Future Outbreaks

The New Ebola Clinical Trial That's Focused on Helping Halt Future Outbreaks

5 Ways Johnson & Johnson Is on the Fast Track to Helping End AIDS

5 Ways Johnson & Johnson Is on the Fast Track to Helping End AIDS

U.S. FDA Approves Vermox™ Chewable (Mebendazole) For Treatment of Children and Adults With Roundworm and Whipworm Infections

U.S. FDA Approves Vermox™ Chewable (Mebendazole) For Treatment of Children and Adults With Roundworm and Whipworm Infections

mhNOW: How Entrepreneurs, Companies and Organizations Are Coming Together to Improve Mental Health

mhNOW: How Entrepreneurs, Companies and Organizations Are Coming Together to Improve Mental Health

Unseen Enemy: The New Film That Looks at Why Viruses Like Zika, Ebola and Influenza Are So Prevalent

Unseen Enemy: The New Film That Looks at Why Viruses Like Zika, Ebola and Influenza Are So Prevalent

Johnson & Johnson Teams Up With Health Officials Across Brazil to Fight Zika

Johnson & Johnson Teams Up With Health Officials Across Brazil to Fight Zika

The Janssen Pharmaceutical Companies of Johnson & Johnson Partner on an Ambitious Tuberculosis Program in India

The Janssen Pharmaceutical Companies of Johnson & Johnson Partner on an Ambitious Tuberculosis Program in India

Our 2030 Promise

Johnson & Johnson has signed up to the 2030 UN Sustainable Development Goals—the world’s road map for progress.

Learn More About Our Initial 5-Year SDG Commitment (2016 – 2020)

More From Johnson & Johnson

Health & Wellness

3 Self-Care Trends That Are Changing How People Look After Their Health

3 Self-Care Trends That Are Changing How People Look After Their Health

More and more consumers are focusing on personal wellness—and Johnson & Johnson's Future of Self Care Team is dedicated to helping them, with innovative ideas for boosting immunity, quitting smoking and more.

Woman with dark hair in a ponytail wearing a red shirt meditating

Latest News

Johnson & Johnson Launches a Health Equity Innovation Challenge in 6 U.S. Cities

Johnson & Johnson Launches a Health Equity Innovation Challenge in 6 U.S. Cities

The company is calling for ideas from applicants in Chicago, Detroit, Los Angeles, New Orleans, New York City and Philadelphia with the aim of helping to address racial healthcare disparities at the local level.

A father and baby look out the window

Innovation

3 Innovative Ways One Company Is Helping Rethink How We Treat Mental Healthcare

3 Innovative Ways One Company Is Helping Rethink How We Treat Mental Healthcare

From scientists in research labs to CEOs at companies across the country, here's how one healthcare company is partnering with people from all walks of life to help drive change in how we treat mental disorders—and the stigma often associated with them.